Hemostats Market Analysis – Industry Specific Opportunities and Trends Affecting the Growth

Hemostat is referred to as a surgical agent that regulates and controls the bleeding process during surgical procedures. Hemostats help to shorten surgery time and reduce the need for blood transfusions. Hemostatic agents are essential in establishing hemostasis in pre-hospital conditions and preventing death associated with hemorrhage. Hemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used as an adjunct to surgical procedures to manage bleeding. Hemostatic agents offer different benefits, which include decreased wound healing & operative time, better management of anti-coagulated patients, and a reduction in the patient recovery period. The Hemostats Market size was USD 3.7 Billion in 2023 and is anticipated to reach USD 6.1 Billion in 2033, growing at a rate of 4.8% from 2024 to 2033.